Monthly Archives: June 2020

Prance Gold Opens up Its Asia Pacific Regional Office in Shenzhen

TOKYO, JAPAN / ACCESSWIRE / June 16, 2020 / Prance Gold Holdings is a cutting edge end-to-end company that offers digital asset holders an opportunity to grow their assets. The multi-sector company opened its Asia Pacific regional office in Shenzhen, a world-renowned technology hub in China, showing the company's continuous growth in serving global clients.

Prance Gold virtually launched its newest office through Zoom on May 23 to over 3,000 audiences. During the tour, the company introduced its hard-working employees, who ensures the overall success of the platform. It also highlighted the continued commitment to serving its clients by providing the support they need in growing their digital assets. Overall, the grand launch of their Shenzhen office was a huge success.

The company is quick at adapting to the ever-changing landscape of the digital world. In fact, Prance Gold was able to successfully digitalize the entire business processes, business model, domain, and organization culture. It is heading towards more innovative developments to continue supporting the platform experience and its trading technology.

"Our Prance Gap-Optimizing-Local-Digitalization (GOLD) Algorithm (PGA) is one of the highly coveted bots in the crypto trading world. It is a high-speed trading bot developed for triple directional arbitrage trades on multiple exchanges. The PGA is in the perfect position to adapt and leverage on the digital market that is continuously changing," Andre Gerald, Chief Executive Officer of Prance Gold Holdings, said.

With the constant economic change that is happening globally, investment platforms such as Prance Gold must find innovative ways to cope with volatile markets. The company has been using an advanced AI bot that extracts, collects, and analyzes live trading information from different exchanges around the globe to produce profitable arbitrage pairs in any kind of economic climate.

Apart from being operational 24/7, PGA offers ultra-short-term trading that allows anyone to park their digital asset for as little as seven hours. The bot will do the trading for you.

The launch of the Shenzhen office marks yet another milestone for Prance Gold Holdings in steering towards a progressive future.

About Prance Gold Holdings

Prance Gold Holdings is headquartered in Seychelles. The company's main business model is to absorb various loans and quickly pay off the interest according to the amount and terms of the loan. At the same time, it also provides loans to major companies that have stable and reliable projects who need short-term funding.

Media Contact

For inquiries, please get in touch with Linda Fairbrother at lindafairbrother@prancegoldholdings.com.

SOURCE: Prance Gold Holdings

ReleaseID: 594143

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of the Following Companies: Allakos, Inc. (Nasdaq – ALLK), Enphase Energy, Inc. (Nasdaq – ENPH), MoSys, Inc. (Nasdaq – MOSY)

BALA CYNWYD, PA / ACCESSWIRE / June 16, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims regarding the following companies for possible breaches of fiduciary duty and other violations of state law. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590. There is no cost or financial obligation to you.

Allakos, Inc. (Nasdaq:ALLK)

The investigation concerns whether the Allakos Board failed to comply with state law and whether that failure to comply contributed to a reduction in share value. For example, on June 11, 2020, the stock closed at $73.85 and is trading well below the 52-week high of $133.99.

Click here to learn more, http://www.brodskysmith.com/cases/allakos-inc-nasdaqgs-allk, or call: 877-534-2590. There is no cost or obligation to you.

Enphase Energy, Inc. (Nasdaq:ENPH)

The investigation concerns whether the Enphase Board failed to comply with state law and whether that failure to comply contributed to a reduction in share value. For example, on June 15, 2020, the stock closed at $50.45 and is trading well below the 52-week high of $70.36.

Click here to learn more, http://www.brodskysmith.com/cases/enphase-energy-inc-nasdaqgm-enph, or call: 877-534-2590. There is no cost or obligation to you.

MoSys, Inc. (Nasdaq:MOSY)

The investigation concerns whether the Mosys Board failed to comply with state law and whether that failure to comply contributed to a reduction in share value. For example, on June 15, 2020, the stock closed at $1.92 and is trading well below the 52-week high of $4.65.

Click here to learn more, http://www.brodskysmith.com/cases/mosys-inc-nasdaqgs-mosy, or call: 877-534-2590. There is no cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 594111

SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm – WLTW, FNJN, IFF

NEW YORK, NY / ACCESSWIRE / June 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures, and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Willis Towers Watson Public Limited Company (NASDAQ:WLTW)

The investigation concerns whether Willis Towers and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the sale of Willis Towers to Aon plc for 1.08 Aon ordinary shares for each Willis Towers ordinary share. If you are a Willis Towers shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/willis-towers-watson-public-limited-company-wltw-stock-merger-aon-plc/.

Finjan Holdings, Inc. (NASDAQ:FNJN)

The investigation concerns whether Finjan and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Finjan to affiliates of Fortress Investment Group LLC for $1.55 per share in cash. If you are a Finjan shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/finjan-holdings-inc-fnjn-fortress-stock-merger/.

International Flavors & Fragrances Inc. (NYSE:IFF)

The investigation concerns whether IFF and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed merger between IFF and DuPont's Nutrition & Biosciences business. If you are an IFF shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/international-flavors-fragrances-inc-iff-stock-merger-dupont/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

CONTACT:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP

ReleaseID: 594123

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Phoenix Tree Holdings Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 16, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Phoenix Tree Holdings Limited ("Phoenix Tree" or "the Company") (NYSE:DNK) for violations of the federal securities laws.

Investors who purchased the Company's American Depositary Shares ("ADSs") pursuant and/or traceable to prospectuses and registration statements issued in connection with the Company's January 22, 2020 initial public offering ("IPO"), are encouraged to contact the firm before June 26, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Phoenix Tree misrepresented the number and nature of renter complaints before its IPO. The Company also misrepresented its exposure to adverse effects on the rental market in China due to the Wuhan coronavirus. Following its IPO, reports exposed that Phoenix Tree experienced significant financial problems based on the coronavirus outbreak. Based on these facts, the Company's public statements and Registration Statements were false and materially misleading. When the market learned the truth about Phoenix Tree, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 594121

SHAREHOLDER ALERT: CONN R FSCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / June 16, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Conn's, Inc. (NASDAQ:CONN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/conns-inc-loss-submission-form?prid=7384&wire=1
Lead Plaintiff Deadline: July 14, 2020
Class Period: September 3, 2019 – December 9, 2019

Allegations against CONN include that: (1) Conn's was experiencing an increase in first payment defaults and 60-plus day delinquencies; (2) as a result, Conn's was reasonably likely to record an increase to its provision for bad debts; (3) the Company made certain underwriting adjustments, including tightening its standards for new customers and online applicants; (4) as a result, the Company's same-store sales would be adversely impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Ryder System, Inc. (NYSE:R)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/ryder-system-inc-loss-submission-form?prid=7384&wire=1
Lead Plaintiff Deadline: July 20, 2020
Class Period: July 23, 2015 – February 13, 2020

Allegations against R include that: (1) Ryder's financial results were inflated as a result of the Company's practice of overstating the residual values of the vehicles in its fleet; (2) there was no reasonable basis to believe that Ryder would sell its used vehicles for the amounts that it had assigned to them; (3) Ryder's residual values for its fleet of vehicles exceeded the expected future values that would be realized upon the sale of those vehicles; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Forescout Technologies, Inc. (NASDAQ:FSCT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/forescout-technologies-inc-loss-submission-form-2?prid=7384&wire=1
Lead Plaintiff Deadline: August 10, 2020
Class Period: February 6, 2020 – May 15, 2020

Allegations against FSCT include that: (1) Forescout was experiencing a significant and disproportionate decline in its financial performance; (2) the foregoing was reasonably likely to have a material negative impact on Forescout's planned acquisition by Advent International Corp.; and (3) as a result of the foregoing, defendants' statements about its business and operations were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 594106

Steroids Market Share, Trends, Growth, Sales, Demand, Revenue, Size and Forecast to 2014-2026

The report analyzes steroid product analysis, market trends, market share, major development regions, and the situation of major players.

New York, United States – June 16, 2020 /MarketersMedia/

Steroids are the general term for a large class of cyclopentane-condensed fully hydrogenated phenanthrene derivatives widely distributed in the biological world. Steroids are mainly synthesized and secreted by various parts of the human body, and a small part can be artificially synthesized, which plays an important auxiliary role in the functional activities of organs, tissues, and cells of the body.

Steroids are prominent in the chemical industry and are the second largest class of drugs after antibiotics. Steroid drugs play an important regulatory role in the human body, including improving protein metabolism, restoring and enhancing physical strength, diuretic and antihypertensive, etc.; and can treat a variety of diseases. Due to the irreplaceable use of steroid drugs and the continuous expansion of their treatment indications, people are paying more and more attention to them.

There is a positive relationship between drug consumption and the economic level. After economic growth, people’s expectations for quality of life increase, tolerance to illness decreases, and the requirement for treatment effects increases, which has led to an increase in drug consumption.

But the abuse of steroids can bring many side effects. It can cause acne and male breast enlargement; when severe, it can threaten life, such as causing heart disease and liver cancer. The side effects of steroids hinder the development of the industry market.

Get FREE Sample of Steroids Market Report at:
https://www.globalmarketmonitor.com/request.php?type=3&rid=546693

The Major Players Profiled in This Report Include:
Valeant
Endo Pharmaceuticals Solutions Inc.
Germiphene Corporation
Taro Pharmaceuticals Inc.
Antares Pharma Inc.
Actavis Pharma Inc.
Sandoz,Pfizer
Unimed Pharmaceuticals
Upsher-Smith

The industry has high technical requirements for the production process route of strains. Different technologies and processes will have a greater impact on the production cycle, product quality, and product production costs. The core competitiveness of an enterprise is reflected in the advanced nature of its technologies and processes, and its ability to continuously upgrade and optimize these technologies and processes. The vast majority of enterprises in the industry usually take strict confidentiality measures to protect product production technology. All these factors form a high technical barrier for new entrants.

The Type and Application Analysis:
On the basis of type, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into:
Corticosteroids
Sex Steroids
Others

On the basis of application, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each application/end users, primarily divided into:
Medical
Food
Cosmetic
Others

To Identify the Key Trends in the Industry, Click on the Link Below:
https://www.globalmarketmonitor.com/reports/546693-steroids-market-report.html

The global manufacturers of steroid drugs are mainly a few large multinational pharmaceutical companies, such as Pfizer, Bayer, Merck, Sanofi-Aventis, etc. In recent years, under the influence of factors such as rising environmental protection costs and rising prices of raw materials and labor, traditional chemical raw materials in developed countries have no advantage. Due to the obvious advantages of raw materials in the Asia-Pacific region and the continuous improvement of production processes, there has been an industrial shift in the production of global steroid drugs. China has gradually become the world’s steroid production center.

Get the Complete Table of Content Immediately

Steroids Report Table of Content:
Chapter 1 Report Overview
Chapter 2 Market Trends and Competitive Landscape
Chapter 3 Segmentation of Steroids Market by Types
Chapter 4 Segmentation of Steroids Market by End-Users
Chapter 5 Market Analysis by Major Regions
Chapter 6 Product Commodity of Steroids Market in Major Countries
Chapter 7 North America Steroids Landscape Analysis
Chapter 8 Europe Steroids Landscape Analysis
Chapter 9 Asia Pacific Steroids Landscape Analysis
Chapter 10 Latin America, Middle East & Africa Steroids Landscape Analysis
Chapter 11 Major Players Profile
11.1 Valeant

11.1.1 Valeant Company Profile and Recent Development

11.1.2 Market Performance

11.1.3 Product and Service Introduction

11.2 Endo Pharmaceuticals Solutions Inc.

11.2.1 Endo Pharmaceuticals Solutions Inc. Profile and Recent Development

11.2.2 Market Performance

11.2.3 Product and Service Introduction

11.3 Germiphene Corporation

11.3.1 Germiphene Corporation Company Profile and Recent Development

11.3.2 Market Performance

11.3.3 Product and Service Introduction

Chapter 12 Data Source and Research Methodology
The List of Tables and Figures

Inquire More or Share Questions if Any Before the Purchase on Steroids Report:
https://www.globalmarketmonitor.com/request.php?type=3&rid=546693

Note: If you have any questions or special requirements, please let us know and custom report is available.

Steroids Report Provide:
Potential opportunities and challenges analysis in the Steroids market.
Current and future market outlook in the developed and emerging regional markets.
Detailed analysis of the segment that is expected to dominate the market.
Regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares, and strategies employed by the major market players.
Comprehensive & in-depth research and after-sales warranty by Global Market Monitor.
Analysis of Influences of COVID-19 to the present and future Steroids market and related industry.

Contact Info:
Name: Quella
Email: Send Email
Organization: Market Monitor
Address: One Pierrepont Plaza, 14th Floor, 300 Cadman Plaza W,Brooklyn, NY 11201, USA
Phone: + 1 (347) 467 7721
Website: https://www.globalmarketmonitor.com/

Source URL: https://marketersmedia.com/steroids-market-share-trends-growth-sales-demand-revenue-size-and-forecast-to-2014-2026/88963597

Source: MarketersMedia

Release ID: 88963597

Innovative Preclinical Oncology Models Added to Creative Bioarray’s Unique Platform Designed to Accelerate Drug Discovery Workflow

Creative Bioarray, the world’s leading biotechnology products and services provider, today announced the expansion of its innovative oncology models which include Syngeneic models, Patient-derived Xenograft (PDX) Models, and Humanized Mouse Models etc.

New York, USA – June 16, 2020 /MarketersMedia/

Creative Bioarray, the world’s leading biotechnology products and services provider, today announced the expansion of its innovative oncology models which include Syngeneic models, Patient-derived Xenograft (PDX) Models, and Humanized Mouse Models etc. This marks a significant milestone in the development of Creative Bioarray’s innovative preclinical platform for oncology drug discovery services.

Cancer research relies highly on representative and reliable model systems. However, cancer is not a tumor defined by a single molecule, but a heterogeneous and highly variable complex of different diseases, which makes the study of cancer very difficult and requires a lot of resources. The models used in cancer research are constantly changing and extend to all stages of drug discovery, including target identification, lead structure optimization, biomarker analysis, tolerance, toxicity, and individual patient prediction.

Creative Bioarray offers a broad range of well-characterized xenograft, patient-derived xenograft (PDX), syngeneic tumor models as well as genetically engineered mouse models (GEMMs). If the mechanism of action needs to be implemented in the complete immune system, the setting of immunosuppression required by the xenograft model will not be suitable for efficacy evaluation. In this case, a syngeneic model in which the derived tumor cell line and the host animal strain are the same may be more appropriate. Creative Bioarray has established multiple syngeneic models, including breast cancer, lung cancer, colon cancer, and melanoma and lymphoma models.

With an advanced research platform and superb technical team, Creative Bioarray can provide a variety of syngeneic tumor models in multiple formats and is committed to assisting in experimental projects to accelerate research. Syngeneic tumor models are allografts derived from immortalized mouse cancer cell lines, which are derived from the same mouse inbred line. These models are crucial for new immune-based therapies by providing valuable systems for evaluating new single drugs and allowing us to study the way cancer therapies are combined with the functional immune system.

The syngeneic tumor models offered by Creative Bioarray can be widely applied in the research of drug screening, ranging from immuno-based therapy development, therapeutic effect evaluation to drug development.

“Creative Bioarray has one of the most extensive collections of isogenic tumor models in the industry, and we specialize in in situ implantation. Our model is well characterized and benchmarked against the most common immune checkpoint inhibitors and other immunomodulators and combination therapies.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “Our in-house experts are dedicated to assisting our clients in conducting their experimental projects to accelerate research. Using our syngeneic mouse model, customers can inquire about novel immunotherapies and combination therapies.”

About Creative Bioarray
Creative Bioarray is a global drug discovery and development service company providing professional platforms to advance oncology, drug development, and many other disease research. With an extensive portfolio of relevant oncology models and predictive tools, Creative Bioarray enables clients to deliver superior clinical candidates. For more information, visit: https://www.creative-bioarray.com/.

Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Phone: 6316197922
Website: https://www.creative-bioarray.com/

Source URL: https://marketersmedia.com/innovative-preclinical-oncology-models-added-to-creative-bioarrays-unique-platform-designed-to-accelerate-drug-discovery-workflow/88963625

Source: MarketersMedia

Release ID: 88963625

Oracle Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / June 16, 2020 / Oracle Corp. (NYSE:ORCL) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on June 16, 2020 at 5:00 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/64478

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 594013

H&R Block, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / June 16, 2020 / H&R Block, Inc. (NYSE:HRB) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on June 16, 2020 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/64350

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 594017

Waydoo Introduces Flyer ONE, the “Flying Surfboard” EFoil with Groundbreaking “All-in-ONE” Technology on Kickstarter

Waydoo has recently introduced the Flyer ONE, a versatile all-in-one electric hydrofoil (“eFoil”), which features a first-class, powerful electric propulsion system that can reach a top speed of 25mph (42km/h).

LOS ANGELES, United States – June 16, 2020 /MarketersMedia/

Waydoo has recently introduced the Flyer ONE, a versatile all-in-one electric hydrofoil (“eFoil”). The Flyer ONE is an exciting new addition to the world of hydrofoil surf sports from the up-and-coming watersports technology developer, Waydoo. Waydoo’s innovative new eFoil is now available for supporters to back on Kickstarter.

Water sports enthusiasts can now experience the thrilling sensation of flying in any body of water. Without the typical weather condition limitations of traditional hydrofoils, the Flyer ONE can be enjoyed anytime, anywhere. The Flyer ONE presents a unique opportunity for adventure seekers from all walks of life to explore oceans, lakes, and rivers like never before.

The Flyer ONE features a first-class, powerful electric propulsion system that can reach a top speed of 25mph (42km/h). The high-efficiency PowerFlight battery rapidly recharges in just two hours and can provide an impressive 55-85 minutes of ride time. Waydoo’s latest eFoil offers unbeatable safety features in a high-performance package. Using the handheld Bluetooth Jet ONE controller, riders always have full control over their speed and can choose between a variety of kneeling, sitting, and standing positions.

“We see a huge potential market in watersports entertainment, due to the rapid rise in popularity of e-foiling,” commented Bianca Zhang, co-founder of Waydoo. “With our integrated supply chain and over 10 years of research and design expertise, our aim via this Kickstarter campaign is to make the cutting-edge new Waydoo Flyer ONE an accessible luxury option for water adventurers.”

Waydoo Flyer ONE’s Specs and Features

● Jet ONE Controller: Riders can select between 24-speed options, including beginner, intermediate, to advanced proficiency modes. Speed, gear, and battery information is easily visible on the handheld Bluetooth controller’s anti-glare screen display and riders can easily view all of their riding data on the Waydoo App using the integrated GPS tracking function.
● FlightFreeze: To ensure the safety of all riders, Waydoo’s proprietary safety feature will automatically stop the propeller if you fall off, once you release a trigger.
● PowerFlight Cell Battery: Waydoo’s high efficiency, fast charging lithium-ion battery completely recharges in two hours, provides 55-85 minutes of ride time, and is interchangeable with other PowerFlight batteries.
● Speed Lock Mode: Designed with younger or amateur riders in mind, the Speed Lock Mode feature ensures comfort and safety by limiting high speeds.
● Accessories: The optional Flyer ONE supportive inflator accessory can transform a rider’s experience by offering increased stability, and lowering the chance of falling into the water.

Waydoo’s Flyer ONE offers a superior, hassle-free set-up. Riders no longer need to fuss with gel application, cables, electrical contacts, or other complicated preparation. The board, mast, and fin can be assembled easily with the six screws provided and the detachable PowerFlight Cell can be installed with a simple push. The Flyer ONE offers fully customizable color and length options, and a range of mast sizes are available for enhanced agility and higher performance.

While similar eFoils on the market set customers back up to $12,000 USD, Waydoo Flyer ONE boasts high quality, innovative features without the hefty price tag. For a limited time only, the Waydoo Flyer ONE is available to consumers through Kickstarter for $3795 USD – a 20% discount off its regular $4795 USD retail price.

About Waydoo

Founded in 2018, Waydoo was born as a startup project that invests and manufactures intelligence hardware for water sports enthusiasts. With over 10 years of industry background and product development experience, Waydoo’s R&D team ensures high quality, innovative technology in all its water sports products. Waydoo’s first product, the Waydoo Flyer was designed and developed within a year and came to market in Q3 2019.

Contact Info:
Name: Bianca Zhang
Email: Send Email
Organization: Waydoo Tech
Website: http://www.waydootech.com

Source URL: https://marketersmedia.com/waydoo-introduces-flyer-one-the-flying-surfboard-efoil-with-groundbreaking-all-in-one-technology-on-kickstarter/88963582

Source: MarketersMedia

Release ID: 88963582